Logo image
Iron-Mediated Inhibition of Mitochondrial Manganese Uptake Mediates Mitochondrial Dysfunction in a Mouse Model of Hemochromatosis
Journal article   Open access   Peer reviewed

Iron-Mediated Inhibition of Mitochondrial Manganese Uptake Mediates Mitochondrial Dysfunction in a Mouse Model of Hemochromatosis

Hani A Jouihan, Paul A Cobine, Robert C Cooksey, Emily A Hoagland, Sihem Boudina, E Dale Abel, Dennis R Winge and Donald A McClain
Molecular medicine (Cambridge, Mass.), Vol.14(3-4), pp.98-108
2008
DOI: 10.2119/2007-00114.Jouihan
PMCID: PMC2258172
PMID: 18317567
url
https://doi.org/10.2119/2007-00114.JouihanView
Published (Version of record) Open Access

Abstract

Previous phenotyping of glucose homeostasis and insulin secretion in a mouse model of hereditary hemochromatosis ( Hfe −/− ) and iron overload suggested mitochondrial dysfunction. Mitochondria from Hfe −/− mouse liver exhibited decreased respiratory capacity and increased lipid peroxidation. Although the cytosol contained excess iron, Hfe −/− mitochondria contained normal iron but decreased copper, manganese, and zinc, associated with reduced activities of copper-dependent cytochrome c oxidase and manganese-dependent superoxide dismutase (MnSOD). The attenuation in MnSOD activity was due to substantial levels of unmetallated apoprotein. The oxidative damage in Hfe −/− mitochondria is due to diminished MnSOD activity, as manganese supplementation of Hfe −/− mice led to enhancement of MnSOD activity and suppressed lipid peroxidation. Manganese supplementation also resulted in improved insulin secretion and glucose tolerance associated with increased MnSOD activity and decreased lipid peroxidation in islets. These data suggest a novel mechanism of iron-induced cellular dysfunction, namely altered mitochondrial uptake of other metal ions.

Details

Metrics

Logo image